PrecisePK Celebrates Four Decades of Precise Dosing and EHR Innovations

Celebrating 40 Years of Precision Dosing with PrecisePK

In a monumental milestone, PrecisePK, a leader in therapeutic drug monitoring (TDM) software, proudly commemorates over 40 years of its commitment to precision dosing. Founded in 1985 at UC San Diego, PrecisePK has cemented itself as an essential tool utilized by healthcare systems around the globe, transforming the way pharmacists and clinicians care for patients.

This year, PrecisePK is shining a spotlight on its pioneering electronic health record (EHR) integrations that facilitate safer and more efficient pharmacist workflows. With seamless connections to major EHR systems such as Epic, Cerner, and Sentri7, PrecisePK is streamlining data management and empowering pharmacists to focus more time on patient care.

Integrations That Matter

One of the standout features of PrecisePK is its ability to directly integrate with existing EHR systems used by pharmacists. For instance, through collaborations with both Epic and Cerner (Oracle Health), PrecisePK automatically imports vital data such as vancomycin doses, administration times, laboratory results, and more. This eradicates the need for manual data entry—a task that was not only time-consuming but also a potential source of error.

Anjum Gupta, the CEO of PrecisePK, aptly stated, “More than 40 years ago, this company was created to enhance the precision of dosing decisions. Today, that same standard of accuracy applies to the data that informs those decisions, ensuring each value from Epic, Cerner, or Sentri7 is handled with our rigorous validation processes.”

The collaboration with Sentri7, Wolters Kluwer's clinical surveillance platform, further exemplifies PrecisePK's commitment to improving clinician workflows. This partnership enables pharmacists to launch PrecisePK directly from a patient’s case in Sentri7, with demographics, dosing history, and lab values transferred seamlessly, eliminating unnecessary logins and manual data re-entry.

Comprehensive Support and Validation

PrecisePK doesn’t stop at integration; they offer extensive drug coverage support across various classes including vancomycin, aminoglycosides, and specific oncology and cardiology medications. Each drug model undergoes rigorous clinical validation by an expert team and partner hospitals to ensure precision and reliability before market release.

Moreover, PrecisePK has a well-structured implementation timeline that lasts between four to seven weeks, involving pre-setup, configuration, and validation. Throughout this process, PrecisePK adheres strictly to HIPAA standards, ensuring enterprise-grade security for all sensitive healthcare data.

A Global Impact

With its extensive history and significant advancements in precision dosing, PrecisePK currently supports health systems in over 20 countries, aiding healthcare professionals in making safer and better-informed medication decisions. The platform has become a trusted resource for academic medical centers, community hospitals, and government health systems alike.

As PrecisePK looks forward, the company's unwavering commitment remains, focusing on advancing precision dosing technology and continuously improving clinical workflows for healthcare professionals. This dedication not only benefits healthcare teams but ultimately enhances patient care on a global scale.

For more information about PrecisePK and its innovative solutions, visit www.precisepk.com.

Conclusion

With over four decades of excellence and innovation in precision dosing, PrecisePK stands as a testament to the power of technology in healthcare, providing tools that enable clinicians to deliver the highest level of care. As we move forward, the focus will likely remain on refining these advancements to ensure that patient safety and efficiency in pharmacological practices continue to be at the forefront.